Catalent

J&J Signs two new Covid-Vaccine Pacts

As part of a plan to establish a network of manufacturing partners to help boost capacity ahead of a potential FDA approval of a Covid-19 vaccine, US healthcare giant Johnson & Johnson (J&J) recently signed agreements with two US companies.

Catalent Acquires MaSTherCell Global

Catalent Appoints Ricci Whitlow as President of Clinical Supply Services

Experts Statements: Jessica Cao, Catalent

The Pharma CDMO Challenge

Catalent Buys Facilities in US and Italy

Catalent Buying BMS Site in Italy

Catalent Expands German Softgel Output

Catalent to Buy Paragon Bioservices for $1.2 Billion

Catalent Appoints Kay Schmidt as Senior Vice President of Technical Operations

Catalent Invests $200 Million on Biologics

M&A in Pharma and CRO/CMO Industry

A Wide Spectrum of Contract Services

Catalent Pays $133 Million for Juniper Pharmaceuticals

Graham Brearley Appointed as General Manager of Catalent’s US Facility at Madison

Catalent and Valerius Link on Biosimilars

Catalent Biologics Restructures Biologics Business

Along the Acquisition Trail

Catalent Completes Expansion at Singapore Facility

Pharma R&D Productivity Needs Improvement

M&A in Pharma and CRO/CMO Industry

The Expanding Role of Contract Manufacturing

Catalent Pays $950 Million for Cook Pharmica

Catalent Starts Madison Expansion Project

Catalent to Acquire Pharmatek Laboratories

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

Lonza Said to be in Bid to Acquire Catalent

Catalent to Add GMP Space at Singapore

Catalent and Roche Link on SMARTag

Pfizer in Marketing Deal with Catalent

Sharon Johnson to Head Catalent’s Quality, Product Development & Regulatory Affairs

CPhI Worldwide Announces International Advisory Board

Catalent Acquires Micron Technologies

CPhI 2014 Experts Statements: Elliott Berger, VP Global Marketing & Strategy, Catalent

Today’s Challenges, Tomorrow’s Excellence